Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 108.40 billion as of February 21, 2025. Its market cap has increased by 40.88% in one year.

Market Cap

108.40B

Enterprise Value

122.44B

Revenue

22.97B

Ranking

n/a

PE Ratio

282.71

Stock Price

109.45

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 138.73M to 108.40B, an increase of 78,034.50%. That is a compound annual growth rate of 22.29%.

Market Cap History

Date	Market Cap	% Change
Feb 21, 2025	108.40B	17.88%
Dec 31, 2024	91.95B	16.03%
Dec 29, 2023	79.25B	-11.32%
Dec 30, 2022	89.37B	32.86%
Dec 31, 2021	67.26B	25.75%
Dec 31, 2020	53.49B	-13.83%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	181.54B
Shell	161.28B
HSBC Holdings	157.51B
Unilever	108.50B
Rio Tinto Group	86.77B
RELX PLC	72.31B
BP p.l.c.	70.06B
British American Tobacco p.l.c.	65.17B

Market Cap Rankings